Showing results (81-90 of 109) with videos related to
Sort By:
Pageof 11
Blood|March 20, 2015
NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCTMobin A Karimi, Jerrod L Bryson, Lee P Richman, et al.The Journal of Clinical Investigation|October 21, 2014
Cytokine therapy reverses NK cell anergy in MHC-deficient tumorsMichele Ardolino, Camillia S Azimi, Alexandre Iannello, et al.Cancer Cell|June 15, 2021
Innate immune cells in the tumor microenvironmentMing O Li, Natalie Wolf, David H Raulet, et al.Plos Pathogens|June 14, 2016
Bacterial Manipulation of NK Cell Regulatory Activity Increases Susceptibility to Listeria monocytogenes InfectionSarah E Clark, Holly C Filak, Brandon S Guthrie, et al.Immunity|April 9, 2008
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancyNadia Guerra, Ying Xim Tan, Nathalie T Joncker, et al.Proceedings of the National Academy of Sciences of the United States of America|May 19, 2022
Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I-deficient and MHC I+ tumorsNatalie K Wolf, Cristina Blaj, Lora K Picton, et al.The Journal of Experimental Medicine|December 22, 2004
The role of innate immunity in autoimmunityJean-François Bach, Albert Bendelac, Michael B Brenner, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
NKG2A inhibits invariant NKT cell activation in hepatic injuryToshihiko Kawamura, Kazuyoshi Takeda, Hiroshi Kaneda, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell responseMarielle C Gold, Michael W Munks, Markus Wagner, et al.Blood|January 26, 2013
ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cellsJ Ludovic Croxford, Melissa Li Fang Tang, Meng Fei Pan, et al.Pageof 11